Latest filing published 08 Oct 2026 for Rallybio Corp, €122k. Read the official filing
No signal scores available.
Stephen Uden (chief executive) discloses dealings in Rallybio Corp to SEC (Form 4). Between 28 July 2021 and 6 October 2026, the trades on record add up to 2 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The record was last updated on 8 October 2026 with an option exercise (€122k) in Rallybio Corp. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations